184 related articles for article (PubMed ID: 30195813)
1. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
McKean MA; Amaria RN
Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach.
Davar D; Tarhini AA; Kirkwood JM
Clin Dermatol; 2013; 31(3):237-50. PubMed ID: 23608443
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant immunotherapy for melanoma patients: progress and opportunities.
Sussman TA; Ott PA
ESMO Open; 2024 May; 9(5):102962. PubMed ID: 38626633
[TBL] [Abstract][Full Text] [Related]
4. Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma.
Błoński PJ; Czarnecka AM; Ostaszewski K; Szumera-Ciećkiewicz A; Rutkowski P
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540282
[TBL] [Abstract][Full Text] [Related]
5. Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.
Czarnecka AM; Ostaszewski K; Błoński P; Szumera-Ciećkiewicz A; Kozak K; Placzke J; Borkowska A; Terlecka A; Rogala P; Świtaj T; Sałamacha M; Mitręga-Korab B; Krotewicz M; Dudzisz-Śledź M; Rutkowski P
Eur J Surg Oncol; 2024 May; 50(7):108382. PubMed ID: 38763112
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy for resectable melanoma.
Sharon CE; Karakousis GC
Clin Exp Metastasis; 2024 Jan; ():. PubMed ID: 38281255
[TBL] [Abstract][Full Text] [Related]
7. "To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers.
Garutti M; Buriolla S; Bertoli E; Vitale MG; Rossi E; Schinzari G; Minisini AM; Puglisi F
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708968
[TBL] [Abstract][Full Text] [Related]
8. Treatment of uveal melanoma: where are we now?
Yang J; Manson DK; Marr BP; Carvajal RD
Ther Adv Med Oncol; 2018; 10():1758834018757175. PubMed ID: 29497459
[TBL] [Abstract][Full Text] [Related]
9. SEOM-GEM clinical guidelines for cutaneous melanoma (2023).
Márquez-Rodas I; Muñoz Couselo E; Rodríguez Moreno JF; Arance Fernández AM; Berciano Guerrero MÁ; Campos Balea B; de la Cruz Merino L; Espinosa Arranz E; García Castaño A; Berrocal Jaime A
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38748192
[TBL] [Abstract][Full Text] [Related]
10. Current Melanoma Treatments: Where Do We Stand?
Moreira A; Heinzerling L; Bhardwaj N; Friedlander P
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435389
[TBL] [Abstract][Full Text] [Related]
11. Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy.
Berezowska S; Keyter M; Bouchaab H; Weissferdt A
Adv Anat Pathol; 2024 Apr; ():. PubMed ID: 38595110
[TBL] [Abstract][Full Text] [Related]
12. Case report: Neoadjuvant systemic therapy for melanoma.
Gabuniya N; Khajuria A; Geh JLC; Alsaadi D
Ann Med Surg (Lond); 2020 Jul; 55():177-179. PubMed ID: 32489661
[TBL] [Abstract][Full Text] [Related]
13. The role of immunotherapy in prostate cancer: an overview of current approaches in development.
Risk M; Corman JM
Rev Urol; 2009; 11(1):16-27. PubMed ID: 19390671
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to 'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma': [Annals of Oncology 34 (2023) 806-812].
Sharon CE; Tortorello GN; Ma KL; Huang AC; Xu X; Giles LR; McGettigan S; Kreider K; Schuchter LM; Mathew AJ; Amaravadi RK; Gimotty PA; Miura JT; Karakousis GC; Mitchell TC
Ann Oncol; 2024 Apr; ():. PubMed ID: 38614876
[No Abstract] [Full Text] [Related]
15. ASO Visual Abstract: The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma: An Australian Cohort.
Zijlker LP; Chen H; Spillane AJ; Gonzalez M; Pennington TE; Menzies AM; Lo SN; Ferguson P; Rawson R; Colebatch AJ; Stretch JR; Thompson JF; Ch'ng S; Nieweg O; Shannon KF; Long GV; Scolyer RA; Saw RPM; van Akkooi ACJ
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38758487
[No Abstract] [Full Text] [Related]
16. Has the melanoma information tsunami become a maelstrom?
Thompson JF; Menzies AM
Melanoma Manag; 2017 Dec; 4(4):179-182. PubMed ID: 30190924
[No Abstract] [Full Text] [Related]
17. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Amaria RN; Reddy SM; Tawbi HA; Davies MA; Ross MI; Glitza IC; Cormier JN; Lewis C; Hwu WJ; Hanna E; Diab A; Wong MK; Royal R; Gross N; Weber R; Lai SY; Ehlers R; Blando J; Milton DR; Woodman S; Kageyama R; Wells DK; Hwu P; Patel SP; Lucci A; Hessel A; Lee JE; Gershenwald J; Simpson L; Burton EM; Posada L; Haydu L; Wang L; Zhang S; Lazar AJ; Hudgens CW; Gopalakrishnan V; Reuben A; Andrews MC; Spencer CN; Prieto V; Sharma P; Allison J; Tetzlaff MT; Wargo JA
Nat Med; 2018 Nov; 24(11):1649-1654. PubMed ID: 30297909
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
Blank CU; Rozeman EA; Fanchi LF; Sikorska K; van de Wiel B; Kvistborg P; Krijgsman O; van den Braber M; Philips D; Broeks A; van Thienen JV; Mallo HA; Adriaansz S; Ter Meulen S; Pronk LM; Grijpink-Ongering LG; Bruining A; Gittelman RM; Warren S; van Tinteren H; Peeper DS; Haanen JBAG; van Akkooi ACJ; Schumacher TN
Nat Med; 2018 Nov; 24(11):1655-1661. PubMed ID: 30297911
[TBL] [Abstract][Full Text] [Related]
19. Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected
Hauschild A; Dummer R; Schadendorf D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Schachter J; Lesimple T; Plummer R; Dasgupta K; Haas T; Shilkrut M; Gasal E; Kefford R; Kirkwood JM; Long GV
J Clin Oncol; 2018 Dec; 36(35):3441-3449. PubMed ID: 30343620
[TBL] [Abstract][Full Text] [Related]
20. Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine.
Tarhini A; Kudchadkar RR
Cancer Treat Rev; 2018 Dec; 71():8-18. PubMed ID: 30273812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
